173 related articles for article (PubMed ID: 856462)
1. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
Benjamin RS; Riggs CE; Bachur NR
Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin metabolism in man. Evidence from urinary metabolites.
Takanashi S; Bachur NR
Drug Metab Dispos; 1976; 4(1):79-87. PubMed ID: 3405
[TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
Gewirtz DA; Yanovich S
Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
[TBL] [Abstract][Full Text] [Related]
5. Bilary disposition of adriamycin.
Riggs CE; Benjamin RS; Serpick AA; Bachur NR
Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
[TBL] [Abstract][Full Text] [Related]
6. Alterations in adriamycin efficacy by phenobarbital.
Reich SD; Bachur NR
Cancer Res; 1976 Oct; 36(10):3803-6. PubMed ID: 954004
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperthermia on the in vitro metabolism of doxorubicin.
Dodion P; Riggs CE; Akman SR; Bachur NR
Cancer Treat Rep; 1986 May; 70(5):625-9. PubMed ID: 3708610
[TBL] [Abstract][Full Text] [Related]
8. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
Ehninger G; Stocker HJ; Proksch B; Wilms K
Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
[TBL] [Abstract][Full Text] [Related]
9. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F
Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807
[TBL] [Abstract][Full Text] [Related]
10. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin pharmacokinetics in the rabbit.
Maniez-Devos DM; Baurain R; Trouet A; Lesne M
J Pharmacol; 1985; 16(2):159-69. PubMed ID: 4058012
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
13. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography.
Brenner DE; Galloway S; Cooper J; Noone R; Hande KR
Cancer Chemother Pharmacol; 1985; 14(2):139-45. PubMed ID: 3971478
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
Egfjord M
Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
[TBL] [Abstract][Full Text] [Related]
15. Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner.
Watson E; Chan KK
Cancer Treat Rep; 1976 Nov; 60(11):1611-8. PubMed ID: 1035506
[TBL] [Abstract][Full Text] [Related]
16. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
Preiss R; Sohr R; Kittelmann B; Müller E; Haase D
Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):156-64. PubMed ID: 2714916
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
20. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
Pierce RN; Jatlow PI
J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]